These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3969605)

  • 1. Inhibition of human pancreatic secretion by terbutaline as a potential agent for treating patients with pancreatic fistula.
    Joehl RJ; Nahrwold DL
    Surg Gynecol Obstet; 1985 Feb; 160(2):109-14. PubMed ID: 3969605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of moderate sedation on exocrine pancreas function in normal healthy subjects: a prospective, randomized, cross-over trial using the synthetic porcine secretin stimulated Endoscopic Pancreatic Function Test (ePFT).
    Conwell DL; Zuccaro G; Purich E; Fein S; Vanlente F; Vargo J; Dumot J; O'laughlin C; Trolli P
    Am J Gastroenterol; 2005 May; 100(5):1161-6. PubMed ID: 15842594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic function in patients with Zollinger-Ellison syndrome. Observations concerning acid-bicarbonate secretion ratios.
    Dreiling DA; Greenstein A
    Am J Gastroenterol; 1972 Jul; 58(1):66-72. PubMed ID: 4558375
    [No Abstract]   [Full Text] [Related]  

  • 4. Postprandial pancreatic secretion and plasma hormones in dogs with pancreatic fistula.
    Katada N; Noda A; Hayakawa T
    Am J Gastroenterol; 1983 Nov; 78(11):740-4. PubMed ID: 6637965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of inhibition of pancreatic secretion by the beta-adrenergic agonist, terbutaline.
    Joehl RJ
    Pancreas; 1986; 1(3):232-8. PubMed ID: 2437567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of octreotide (SMS 201-995) on meal-stimulated pancreatic secretion in three patients with external pancreatic fistula.
    Gullo L; Biliotti G; Pezzilli R; Di Stefano M; Ancona D
    Am J Gastroenterol; 1991 Jul; 86(7):892-4. PubMed ID: 2058634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of somatostatin on basal and stimulated pancreatic secretion in conscious rat.
    Takács T; Pap A; Varró V
    Acta Med Hung; 1986; 43(1):45-53. PubMed ID: 2877434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on duodenal cyclic AMP content content in pancreatic disease after administration of pancreozymin and secretin.
    Matsumoto R; Arima T; Tsunashima T; Kawai K; Suwaki K; Tanigawa T; Kita S; Nagashima H
    Am J Gastroenterol; 1980 Aug; 74(2):138-42. PubMed ID: 6255794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of terbutaline-induced inhibition of exocrine pancreatic secretion in humans.
    Meyer B; Hildebrand P; Meyer M; Stalder GA; Beglinger C
    Pancreas; 1988; 3(4):399-403. PubMed ID: 2902621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretin dose-response in health and chronic pancreatic inflammatory disease.
    Petersen H; Myren J
    Scand J Gastroenterol; 1975; 10(8):851-61. PubMed ID: 1202619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Direct determination of secretion capacity of the pancreas after hormonal stimulation. Diagnostic significance of the secretin and pancreozymin tests].
    Herfort K; Fric P; Bartos V
    Dtsch Z Verdau Stoffwechselkr; 1971; 31(4):173-82. PubMed ID: 5150341
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between gastric and pancreatic secretion in patients with duodenal ulcer.
    Petersen H
    Scand J Gastroenterol; 1970; 5(5):321-6. PubMed ID: 5455817
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreatic function testing is best determined by the extended endoscopic collection technique.
    Moolsintong P; Burton FR
    Pancreas; 2008 Nov; 37(4):418-21. PubMed ID: 18953255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vagotomy on pancreatic secretion stimulated by endogenous and exogenous secretin.
    Moreland HJ; Johnson LR
    Gastroenterology; 1971 Mar; 60(3):425-31. PubMed ID: 5554082
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of pancreatic fistula with terbutaline. Report of a case].
    Padilla Longoria R; Blanco Benavides R; Peterson Andres J; Juárez Díaz F; Quijano Orvañanos F
    Arch Invest Med (Mex); 1989; 20(2):153-6. PubMed ID: 2604499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: A comparison of basal and stimulated gastric and pancreatic secretion in patients with and without duodenal ulcer disease.
    Gutierrez LV; Baron JH
    Gut; 1974 Oct; 15(10):836. PubMed ID: 4434957
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of juice obtained during duodenal aspiration and cannulation of the main pancreatic duct after stimulation with exogenous secretin in man.
    Osnes M; Petersen H; Schrumpf E
    Scand J Gastroenterol; 1978; 13(4):453-8. PubMed ID: 675156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric and pancreatic response to acid in the duodenum after partial duodenectomy.
    Way LW; Grossman MI
    Am J Physiol; 1971 Apr; 220(4):1016-9. PubMed ID: 5551129
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of pancreatic secretion under long-term octreotide treatment in humans.
    Friess H; Bordihn K; Ebert M; Malfertheiner P; Kemmer T; Dennler HJ; Büchler MW
    Digestion; 1994; 55 Suppl 1():10-5. PubMed ID: 8132133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: implications for the management of fistulae.
    Jenkins SA; Nott DM; Baxter JN
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):255-8. PubMed ID: 7743308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.